Literature DB >> 2565820

Expression of dipeptidyl peptidase IV in rat tissues is mainly regulated at the mRNA levels.

W J Hong1, J K Petell, D Swank, J Sanford, D C Hixson, D Doyle.   

Abstract

Dipeptidyl peptidase IV (DPPIV) is a serine peptidase that cleaves N-terminal dipeptides from polypeptides when the second residue is a proline or an alanine. We have recently cloned cDNAs for rat gp110, a membrane glycoprotein with Mr of 110,000 isolated initially from rat liver. Studies reported here establish that the gp110 for which we have cloned cDNAs is DPPIV. Using the antibodies against and cDNA for DPPIV, we have assessed the tissue distribution of DPPIV by molecular approaches. Immunoblot analysis demonstrated that DPPIV is present in the kidney, lung, and small intestine at high levels, in the liver and spleen at moderate levels, and in the heart at low levels. The highest levels of mRNA for DPPIV were detected in the kidney and small intestine as compared to moderate levels found in the lung, liver, and spleen. The lowest levels of DPPIV mRNA were found in the stomach, testis, and heart. No detectable DPPIV protein and mRNA were found in brain or muscle. LDPPIV protein and mRNA are present at much lower levels in fetal livers as compared to the adult liver. Indirect immunofluorescence microscopy demonstrated that DPPIV is localized in the bile canaliculus of hematocytes and in the apical membrane domains of kidney tubule and small intestine. Further studies by Southern blot analysis indicate that DPPIV is encoded by a single gene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565820     DOI: 10.1016/0014-4827(89)90296-6

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  25 in total

Review 1.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

Review 2.  Cellular mechanisms of intrahepatic cholestasis.

Authors:  P J Meier-Abt
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Tissue-specific regulation of dipeptidyl peptidase IV expression during development.

Authors:  M Hildebrandt; W Reutter; J D Gitlin
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

4.  Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4.

Authors:  Marcus Lettau; Michelle Dietz; Sarah Vollmers; Fred Armbrust; Christian Peters; Thi Mai Dang; Guranda Chitadze; Dieter Kabelitz; Ottmar Janssen
Journal:  Cell Mol Life Sci       Date:  2019-07-12       Impact factor: 9.261

5.  A Fischer rat substrain deficient in dipeptidyl peptidase IV activity makes normal steady-state RNA levels and an altered protein. Use as a liver-cell transplantation model.

Authors:  N L Thompson; D C Hixson; H Callanan; M Panzica; D Flanagan; R A Faris; W J Hong; S Hartel-Schenk; D Doyle
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

Review 6.  The evolution of proteinase substrates with special reference to dipeptidylpeptidase IV.

Authors:  R E Smith; C J Reynolds; E A Elder
Journal:  Histochem J       Date:  1992-09

7.  Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.

Authors:  Therese S Salameh; Elizabeth M Rhea; Konrad Talbot; William A Banks
Journal:  Biochem Pharmacol       Date:  2020-08-02       Impact factor: 5.858

8.  Protein-restricted diet alters concentration of plasma membrane glycoproteins in rat liver.

Authors:  S Reif; M El-Bendary; Y Bujanover; J K Petell; E Lebenthal
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

9.  Comparative immunohistochemistry and histochemistry of dipeptidyl peptidase IV in rat organs during development.

Authors:  S Hartel-Schenk; R Gossrau; W Reutter
Journal:  Histochem J       Date:  1990-10

Review 10.  GLP-1 and weight loss: unraveling the diverse neural circuitry.

Authors:  Scott E Kanoski; Matthew R Hayes; Karolina P Skibicka
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-30       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.